- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
PPIs use to cause fracture risk in rheumatoid arthritis - Video
Overview
Rheumatoid arthritis is an auto immune disorder that causes pain, swelling, stiffness and loss of function in your joints. It can affect any joint but is common in the wrist and fingers. This greatly affects ones quality of life.
Concomitant use of PPIs and oral glucocorticoids increases risk of osteoporotic fractures by 1.6-fold in rheumatoid arthritis (RA) patients (aged 50 years and above), finds a recent study. The results of the study, published in the BMJ journal Annals of the Rheumatic Diseases, suggests that fracture risk assessment should be considered when a RA patient is prescribed both oral GCs and PPIs.
Rheumatoid arthritis patients commonly use proton pump inhibitors (PPIs) and oral glucocorticoids (GCs) both of which are associated with osteoporotic fractures. Shahab Abtahi, Maastricht University Medical Centre, Maastricht, The Netherlands, and colleagues investigated the association between concomitant use of oral GCs and PPIs and osteoporotic fractures risk among RA patients.
For more information check out the full story on the link below:
PPI, oral glucocorticoids use linked to fracture risk in rheumatoid arthritis patients: BMJ
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)